March 17th 2021
Revenue generating BDA sets its sights on US market
March 2nd 2021
Neurotech expands exclusive license to include all neurological disorders
January 21st 2021
Neurotech’s key near-term objectives
October 13th 2020
$2M in repeat purchase orders display Creso Pharma’s growth potential
May 29th 2020
How (and why) companies are mixing Terpenes into Cannabis Distillates
February 6th 2020
Creso Pharma set to expand human health product line with technological breakthrough
February 5th 2020
Roots extends sales relationship with Israeli cannabis company
January 28th 2020
BPH investee signs JV with cutting edge cannabis researcher
Connect with us